Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition. The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:55:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:50:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T15:47:39.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the requested study page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T16:48:04.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the previous trial content. This prevents viewing trial details, eligibility criteria, and related materials on the page.
    Difference
    19%
    Check dated 2026-09-19T18:11:32.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the ClinicalTrials.gov study page. This change does not modify any study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T20:50:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.